Literature DB >> 8817286

Relationship between optic disc cupping change and intraocular pressure control in adult glaucoma patients.

E Z Rath1, D H Shin, C Kim, C S Tsai, J H Zeiter, Y J Hong.   

Abstract

BACKGROUND: Until recently, there has been a paucity of quantitative evidence for intraocular pressure (IOP)-dependent optic disc cupping change in adult glaucoma patients. Therefore, we investigated the relationship between optic disc cupping change and IOP control.
METHODS: The study involved 78 eyes of 78 randomly selected adult patients with early to moderate chronic open-angle glaucoma (CO-AG), treated on various therapeutic regimens, who had had two consecutive successful optic disc analyses with the Rodenstock Optic Nerve Head Analyzer 15.8 +/- 14.8 weeks apart.
RESULTS: The mean initial IOP of 27 eyes (34%) with cupping reversal did not differ from that of 17 eyes (22%) demonstrating progressive deterioration (29.2 +/- 8.8 vs 26.2 +/- 6.1 mmHg, P > 0.5), but the reversal group did have a significantly greater mean IOP decrease than the progression group (-10.8 +/- 7.9 vs-1.0 +/- 7.7 mmHg, P < 0.001) and significantly lower mean final IOP (18.3 +/- 6.1 vs 25.2 +/- 7.9 mmHg, P < 0.003).
CONCLUSION: A decrease of optic disc cupping is more likely with a greater IOP reduction and a lower final IOP, and an increase of cupping is more likely with less or no IOP reduction and a higher final IOP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817286     DOI: 10.1007/bf02539409

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  Increase of neuroretinal rim area after surgical intraocular pressure reduction.

Authors:  J Funk
Journal:  Ophthalmic Surg       Date:  1990-08

2.  Changes in reversal of cupping in experimental glaucoma. Longitudinal study.

Authors:  M Shirakashi; K Nanba; K Iwata
Journal:  Ophthalmology       Date:  1992-07       Impact factor: 12.079

3.  Reversal of cupping in experimental glaucoma.

Authors:  M Shirakashi; K Nanba; K Iwata
Journal:  Ophthalmologica       Date:  1991       Impact factor: 3.250

4.  Reversible optic disk cupping and visual field improvement in adults with glaucoma.

Authors:  L J Katz; G L Spaeth; L B Cantor; E M Poryzees; W C Steinmann
Journal:  Am J Ophthalmol       Date:  1989-05-15       Impact factor: 5.258

5.  Measurements of reversibility of optic disc cupping and pallor in ocular hypertension and glaucoma.

Authors:  B Schwartz; T Takamoto; P Nagin
Journal:  Ophthalmology       Date:  1985-10       Impact factor: 12.079

6.  Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis.

Authors:  R Wilson; A M Walker; D K Dueker; R P Crick
Journal:  Arch Ophthalmol       Date:  1982-05

7.  Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma.

Authors:  L K Mao; W C Stewart; M B Shields
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

8.  Trabeculectomy.

Authors:  D H Shin
Journal:  Int Ophthalmol Clin       Date:  1981

9.  Long-term studies of visual field changes by means of computerized perimetry (Octopus 201) in eyes with glaucomatous field defects after normalization of the intra-ocular pressure.

Authors:  W Leydhecker; E Gramer
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

10.  Early diagnosis of glaucoma. The value of successive stereophotography of the optic disc.

Authors:  T Odberg; D Riise
Journal:  Acta Ophthalmol (Copenh)       Date:  1985-06
View more
  2 in total

1.  Age related compliance of the lamina cribrosa in human eyes.

Authors:  J Albon; P P Purslow; W S Karwatowski; D L Easty
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  Optic disc changes following trabeculectomy: longitudinal and localisation of change.

Authors:  A Kotecha; D Siriwardena; F W Fitzke; R A Hitchings; P T Khaw
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.